{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:12:30Z","timestamp":1763766750178},"reference-count":101,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>Cancer reporting guidelines have been developed and utilized in many countries throughout the world. The International Collaboration on Cancer Reporting (ICCR), through an alliance of colleges and other pathology organizations in Australasia, United Kingdom, Ireland, Europe, USA, and Canada, has developed comprehensive standardized data sets to provide for global usage and promote uniformity in cancer reporting. Structured reporting facilitates provision of all necessary information, which ensures accurate and comprehensive data collection, with the ultimate aim of improving cancer diagnostics and treatment. The data set for primary carcinoma of the renal pelvis and ureter treated with nephroureterectomy or ureterectomy had input from an expert panel of international uropathologists. This data set was based on current evidence-based practice and incorporated information from the 2016 fourth edition of the World Health Organization (WHO) Bluebook on tumors of the urinary and male genital systems and the 2017 American Joint Committee on Cancer (AJCC) TNM staging eighth edition. This protocol applies to both noninvasive and invasive carcinomas in these locations. Reporting elements are considered to be essential (<jats:italic toggle=\"yes\">required<\/jats:italic>) or nonessential (<jats:italic toggle=\"yes\">recommended<\/jats:italic>). <jats:italic toggle=\"yes\">Required<\/jats:italic> elements include operative procedure, specimens submitted, tumor location, focality and size, histologic tumor type, subtype\/variant of urothelial carcinoma, WHO grade, extent of invasion, presence or absence of vascular invasion, status of the resection margins and lymph nodes and pathologic stage. The data set provides a detailed template for the collection of data and it is anticipated that this will facilitate appropriate patient management with the potential to foster collaborative research internationally.<\/jats:p>","DOI":"10.1097\/pas.0000000000001305","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T09:05:12Z","timestamp":1560416712000},"page":"e1-e12","source":"Crossref","is-referenced-by-count":8,"title":["Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter\u2014Nephroureterectomy and Ureterectomy Specimens"],"prefix":"10.1097","volume":"43","author":[{"given":"Hemamali","family":"Samaratunga","sequence":"first","affiliation":[{"name":"Aquesta Uropathology"},{"name":"University of Queensland School of Medicine, Brisbane, Qld"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meagan","family":"Judge","sequence":"additional","affiliation":[{"name":"Royal College of Pathologists of Australasia, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"Delahunt","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Srigley","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Brimo","sequence":"additional","affiliation":[{"name":"McGill University Health Center, Montr\u00e9al, QC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hopital Tenon, HUEP, Sorbonne University, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Urology, Indiana University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lopez-Beltran","sequence":"additional","affiliation":[{"name":"Department of Pathology, Champalimaud Clinical Center, Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Reuter","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Shanks","sequence":"additional","affiliation":[{"name":"Department of Histopathology, The Christie NHS Foundation Trust, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aichi Medical University, School of Medicine, Aichi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodorus","family":"van der Kwast","sequence":"additional","affiliation":[{"name":"Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Grignon","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, IUH Pathology Laboratory, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0046-8177(91)90209-8","article-title":"Synoptic surgical pathology reporting","volume":"22","author":"Markel","year":"1991","journal-title":"Hum Pathol"},{"key":"R2-20230922","first-page":"481","article-title":"The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas","volume":"51","author":"Cross","year":"1998","journal-title":"J Clin Oncol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/jcp.54.10.809","article-title":"The use of a standard proforma in breast cancer reporting","volume":"54","author":"Mathers","year":"2001","journal-title":"J Clin Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jso.21282","article-title":"Standardized synoptic cancer pathology reporting: a population-based approach","volume":"99","author":"Srigley","year":"2009","journal-title":"J Surg Oncol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/00313020802337329","article-title":"Synoptic reporting improves histopathological assessment of pancreatic resection specimens","volume":"41","author":"Gill","year":"2009","journal-title":"Pathology"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2288-9-34","article-title":"Extending an evidence hierarchy to include topics other than treatment: revising the Australian \u201clevels of evidence\u201d","volume":"9","author":"Merlin","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.eururo.2015.06.044","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial cell carcinoma: 2015 update","volume":"68","author":"Roupret","year":"2015","journal-title":"Eur Urol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ctrv.2015.02.006","article-title":"A contemporary review of management and prognostic factors of upper tract urothelial carcinoma","volume":"41","author":"Leow","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrurol.2015.24","article-title":"Risk-adapted strategy for the kidney-sparing management of upper tract tumours","volume":"12","author":"Seisen","year":"2015","journal-title":"Nat Rev Urol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MOU.0000000000000148","article-title":"Kidney-sparing surgery for upper tract urothelial cancer","volume":"25","author":"Lucca","year":"2015","journal-title":"Curr Opin Urol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1464-410X.2011.10461.x","article-title":"Upper urinary tract transitional cell carcinoma: location is not correlated with prognosis","volume":"109","author":"Milojevic","year":"2012","journal-title":"BJU Int"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2010.07.003","article-title":"The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center","volume":"58","author":"Favaretto","year":"2010","journal-title":"Eur Urol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/j.1464-410X.2011.10792.x","article-title":"Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy","volume":"110","author":"Yafi","year":"2012","journal-title":"BJU Int"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.urolonc.2014.01.022","article-title":"Risk factors for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a meta-analysis","volume":"32","author":"Yuan","year":"2014","journal-title":"Urol Oncol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"59.e9","DOI":"10.1016\/j.urolonc.2015.08.015","article-title":"Lower ureteral lesion is an independent predictor of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"34","author":"Otsuka","year":"2016","journal-title":"Urol Oncol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2012.02.030","article-title":"Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature","volume":"62","author":"Lughezzani","year":"2012","journal-title":"Eur Urol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1464-410X.2010.09341.x","article-title":"Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma","volume":"106","author":"Pieras","year":"2010","journal-title":"BJU Int"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1464-410X.2008.08134.x","article-title":"Independent prognostic value of tumour diameter and tumour necrosis in upper urinary tract urothelial carcinoma","volume":"103","author":"Simone","year":"2009","journal-title":"BJU Int"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2012.01.019","article-title":"Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification","volume":"62","author":"Shariat","year":"2012","journal-title":"Eur Urol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/cncr.10609","article-title":"Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma","volume":"94","author":"Yoshimura","year":"2012","journal-title":"Cancer"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.juro.2014.04.001","article-title":"Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems","volume":"192","author":"Park","year":"2014","journal-title":"J Urol"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2559.2012.04183.x","article-title":"Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification","volume":"61","author":"Sassa","year":"2012","journal-title":"Histopathology"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.urology.2005.09.010","article-title":"Upper urinary tract tumors with nontransitional histology: a single-center experience","volume":"67","author":"Busby","year":"2006","journal-title":"Urology"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.juro.2007.03.033","article-title":"Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome","volume":"178","author":"Holmang","year":"2007","journal-title":"J Urol"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.5858\/arpa.2010-0690-OA","article-title":"Small cell carcinoma of the renal pelvis and ureter: clinicopathologic and immunohistochemical features","volume":"135","author":"Miller","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"446","DOI":"10.6004\/jnccn.2013.0059","article-title":"Bladder cancer","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1097\/PAS.0000000000000240","article-title":"Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R38-20230922","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.3880044","article-title":"Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors","volume":"13","author":"Agoff","year":"2000","journal-title":"Mod Pathol"},{"key":"R39-20230922","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.humpath.2005.04.007","article-title":"Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases","volume":"36","author":"Jones","year":"2005","journal-title":"Hum Pathol"},{"key":"R40-20230922","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/cncr.20903","article-title":"Small cell carcinoma of the urinary bladder. The Mayo Clinic experience","volume":"103","author":"Choong","year":"2005","journal-title":"Cancer"},{"key":"R41-20230922","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.ju.0000132413.85866.fc","article-title":"Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M.D. Anderson cancer experience","volume":"172","author":"Siefker-Radtke","year":"2004","journal-title":"J Urol"},{"key":"R42-20230922","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1097\/00005392-199805000-00058","article-title":"Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival","volume":"159","author":"Mackey","year":"1998","journal-title":"J Urol"},{"key":"R43-20230922","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.eururo.2012.04.020","article-title":"Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center","volume":"64","author":"Lynch","year":"2013","journal-title":"Eur Urol"},{"issue":"suppl 2","key":"R44-20230922","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","article-title":"Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications","volume":"22","author":"Amin","year":"2009","journal-title":"Mod Pathol"},{"key":"R45-20230922","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.humpath.2006.05.009","article-title":"Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications","volume":"37","author":"Lopez-Beltran","year":"2006","journal-title":"Hum Pathol"},{"key":"R46-20230922","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.juro.2012.04.009","article-title":"Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma","volume":"188","author":"Rink","year":"2012","journal-title":"J Urol"},{"key":"R47-20230922","doi-asserted-by":"crossref","first-page":"204.e9","DOI":"10.1016\/j.urolonc.2015.02.010","article-title":"Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy","volume":"33","author":"Shibing","year":"2015","journal-title":"Urol Oncol"},{"key":"R48-20230922","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/modpathol.3800559","article-title":"High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants","volume":"19","author":"Perez-Montiel","year":"2006","journal-title":"Mod Pathol"},{"key":"R49-20230922","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.humpath.2017.05.001","article-title":"Variant morphology in upper urinary tract urothelial carcinoma: a 14-year case series of biopsy and resection specimens","volume":"65","author":"Hayashi","year":"2017","journal-title":"Hum Pathol"},{"key":"R50-20230922","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00345-013-1141-0","article-title":"Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"32","author":"Masson-Lecomte","year":"2014","journal-title":"World J Urol"},{"key":"R51-20230922","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"key":"R52-20230922","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.urolonc.2010.01.001","article-title":"Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy","volume":"30","author":"Wheat","year":"2012","journal-title":"Urol Oncol"},{"key":"R53-20230922","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00345-011-0645-8","article-title":"Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients","volume":"29","author":"Otto","year":"2011","journal-title":"World J Urol"},{"key":"R54-20230922","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R56-20230922","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/modpathol.2014.158","article-title":"Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer","volume":"28","author":"Amin","year":"2015","journal-title":"Mod Pathol"},{"key":"R57-20230922","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8","article-title":"Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"R58-20230922","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-4295(02)01705-3","article-title":"Comparison of WHO\/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression","volume":"60","author":"Samaratunga","year":"2002","journal-title":"Urology"},{"key":"R59-20230922","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25122","article-title":"Highly predictive survival nomogram after upper urinary tract urothelial carcinoma","volume":"116","author":"Jeldres","year":"2010","journal-title":"Cancer"},{"key":"R60-20230922","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1464-410X.2012.11066.x","article-title":"Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients","volume":"110","author":"Grasso","year":"2012","journal-title":"BJU Int"},{"key":"R61-20230922","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","article-title":"Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review","volume":"110","author":"Cutress","year":"2012","journal-title":"BJU Int"},{"key":"R62-20230922","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","article-title":"Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"key":"R63-20230922","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12631","article-title":"Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and\/or locally advanced upper tract urothelial carcinoma without metastasis","volume":"114","author":"Seisen","year":"2014","journal-title":"BJU Int"},{"key":"R64-20230922","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.juro.2012.10.057","article-title":"Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis","volume":"189","author":"Roupret","year":"2013","journal-title":"J Urol"},{"key":"R65-20230922","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00428-004-1039-8","article-title":"Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group","volume":"445","author":"Lopez-Beltran","year":"2004","journal-title":"Virchows Arch"},{"key":"R66-20230922","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"Babjuk","year":"2013","journal-title":"Eur Urol"},{"key":"R68-20230922","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1464-410X.2006.06672.x","article-title":"A critical appraisal of the classification of urothelial tumours: time for a review of the evidence and a radical change","volume":"99","author":"Harnden","year":"2007","journal-title":"BJU Int"},{"key":"R69-20230922","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"R70-20230922","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/00365590510031219","article-title":"T1 G1 urinary bladder carcinoma: fact or fiction","volume":"39","author":"Mikulowski","year":"2005","journal-title":"Scand J Urol Nephrol"},{"key":"R71-20230922","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/modpathol.2014.154","article-title":"Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications","volume":"28","author":"van Rhijn","year":"2015","journal-title":"Mod Pathol"},{"key":"R72-20230922","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/B:UROL.0000020305.70637.c6","article-title":"Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder","volume":"35","author":"Kruger","year":"2003","journal-title":"Int Urol Nephrol"},{"key":"R73-20230922","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.urology.2010.01.032","article-title":"Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma","volume":"76","author":"Cao","year":"2010","journal-title":"Urology"},{"key":"R74-20230922","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1464-410X.2010.09515.x","article-title":"The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer","volume":"107","author":"Otto","year":"2011","journal-title":"BJU Int"},{"key":"R75-20230922","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2012.09.063","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: pathology","volume":"63","author":"Amin","year":"2013","journal-title":"Eur Urol"},{"key":"R76-20230922","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.juro.2012.11.006","article-title":"Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis","volume":"189","author":"Linder","year":"2013","journal-title":"J Urol"},{"key":"R77-20230922","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00428-014-1601-y","article-title":"Clinicopathological characteristics and outcome of nested carcinoma of the urinary bladder","volume":"465","author":"Lopez-Beltran","year":"2014","journal-title":"Virchows Arch"},{"key":"R78-20230922","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.humpath.2009.07.015","article-title":"Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases","volume":"41","author":"Wasco","year":"2010","journal-title":"Hum Pathol"},{"key":"R79-20230922","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/PAS.0b013e318222a653","article-title":"Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma","volume":"35","author":"Cox","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R80-20230922","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jjco\/hyt120","article-title":"Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system","volume":"43","author":"Nishiyama","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"R81-20230922","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2015.02.021","article-title":"A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma","volume":"68","author":"Patschan","year":"2015","journal-title":"Eur Urol"},{"key":"R82-20230922","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1464-410X.2012.10930.x","article-title":"International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis","volume":"110","author":"Roscigno","year":"2012","journal-title":"BJU Int"},{"key":"R83-20230922","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"R84-20230922","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1245\/s10434-014-4103-x","article-title":"Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location","volume":"22","author":"Lee","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R85-20230922","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.urology.2010.04.020","article-title":"Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma","volume":"76","author":"Abouassaly","year":"2010","journal-title":"Urology"},{"key":"R86-20230922","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.urology.2008.04.032","article-title":"Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma","volume":"72","author":"Bolenz","year":"2008","journal-title":"Urology"},{"key":"R87-20230922","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bju.12116","article-title":"Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy","volume":"111","author":"Hurel","year":"2013","journal-title":"BJU Int"},{"key":"R89-20230922","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1464-410X.2008.07988.x","article-title":"Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node density","volume":"103","author":"Bolenz","year":"2009","journal-title":"BJU Int"},{"key":"R90-20230922","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bju.12801","article-title":"The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study","volume":"116","author":"Lucca","year":"2015","journal-title":"BJU Int"},{"key":"R91-20230922","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.urology.2011.11.058","article-title":"The contemporary role of lymph node dissection during nephroureterectomy in the management of upper urinary tract urothelial carcinoma: the Canadian experience","volume":"79","author":"Mason","year":"2012","journal-title":"Urology"},{"key":"R92-20230922","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.juro.2011.10.158","article-title":"Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma","volume":"187","author":"Fajkovic","year":"2012","journal-title":"J Urol"},{"key":"R93-20230922","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.juro.2012.09.036","article-title":"Prediction of true nodal status in patients with pathological lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy","volume":"189","author":"Xylinas","year":"2013","journal-title":"J Urol"},{"key":"R94-20230922","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.urology.2009.04.084","article-title":"Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer","volume":"74","author":"Roscigno","year":"2009","journal-title":"Urology"},{"key":"R95-20230922","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00345-012-0983-1","article-title":"The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy","volume":"31","author":"Ouzzane","year":"2013","journal-title":"World J Urol"},{"key":"R96-20230922","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1200\/JCO.2005.03.084","article-title":"Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor","volume":"23","author":"Fleischmann","year":"2005","journal-title":"J Clin Oncol"},{"key":"R97-20230922","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2559.2011.03778.x","article-title":"Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer","volume":"58","author":"Seiler","year":"2011","journal-title":"Histopathology"},{"key":"R98-20230922","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1245\/s10434-012-2753-0","article-title":"External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy","volume":"20","author":"Masson-Lecomte","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R99-20230922","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.eururo.2012.09.053","article-title":"Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma","volume":"63","author":"Fritsche","year":"2013","journal-title":"Eur Urol"},{"key":"R100-20230922","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ejso.2010.08.134","article-title":"Role of lymph node dissection in the treatment of urothelial carcinoma of the upper urinary tract: multi-institutional relapse analysis and immunohistochemical re-evaluation of negative lymph nodes","volume":"36","author":"Abe","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R101-20230922","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.pas.0000194296.74097.87","article-title":"Evaluation of the non-neoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive failure","volume":"30","author":"Bijol","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R102-20230922","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/PAS.0b013e31804ca63e","article-title":"Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases","volume":"31","author":"Henriksen","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R103-20230922","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAP.0b013e3181e3c02d","article-title":"The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important","volume":"17","author":"Bonsib","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"R105-20230922","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAP.0b013e31817145a9","article-title":"Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting","volume":"15","author":"Gupta","year":"2008","journal-title":"Adv Anat Pathol"},{"key":"R106-20230922","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.13200","article-title":"UICC drops the ball in the 8th ed. TNM staging of urological cancers","volume":"71","author":"Delahunt","year":"2017","journal-title":"Histopathology"},{"key":"R107-20230922","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.eururo.2012.10.008","article-title":"A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens","volume":"63","author":"Hansel","year":"2013","journal-title":"Eur Urol"},{"key":"R108-20230922","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/jcp.2009.071191","article-title":"Best practice: gross examination and sampling of surgical specimens from the urinary bladder","volume":"63","author":"Chandra","year":"2010","journal-title":"J Clin Pathol"},{"key":"R110-20230922","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1089\/end.2012.0229","article-title":"Outcomes of intrarenal Bacillus Calmette-Guerin\/interferon-alpha2B for biopsy-proven upper-tract carcinoma in situ","volume":"26","author":"Shapiro","year":"2012","journal-title":"J Endourol"},{"key":"R111-20230922","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.eururo.2015.09.048","article-title":"Reply to Yan Shibing and Wei Qiang\u2019s Letter to the Editor re: Morgan Roupret, Marko Babjuk, Eva Comperat, et al European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868\u2013879","volume":"69","author":"Roupret","year":"2016","journal-title":"Eur Urol"},{"key":"R112-20230922","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.juro.2015.02.081","article-title":"Lynch syndrome: a primer for urologists and panel recommendations","volume":"194","author":"Mork","year":"2015","journal-title":"J Urol"},{"key":"R113-20230922","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/hupa.2003.22","article-title":"Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability","volume":"34","author":"Hartmann","year":"2003","journal-title":"Hum Pathol"},{"key":"R114-20230922","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bju.12308","article-title":"Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours","volume":"113","author":"Hollande","year":"2014","journal-title":"BJU Int"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:54:13Z","timestamp":1695423253000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001305"}},"subtitle":["Recommendations From the International Collaboration on Cancer Reporting (ICCR)"],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001305","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}